{"id":42218,"date":"2017-08-22T05:54:53","date_gmt":"2017-08-22T05:54:53","guid":{"rendered":"https:\/\/www.biphoo.com\/bipnews\/?p=42218"},"modified":"2017-08-22T05:54:53","modified_gmt":"2017-08-22T05:54:53","slug":"jj-ordered-pay-417-million-trial-talc-cancer-risks","status":"publish","type":"post","link":"https:\/\/www.biphoo.com\/bipnews\/business\/jj-ordered-pay-417-million-trial-talc-cancer-risks.html","title":{"rendered":"J&J ordered to pay $417 million in trial over talc cancer risks"},"content":{"rendered":"

J&J ordered to pay $417 million in trial over talc cancer risks<\/span><\/strong><\/span><\/h2>\n

J&J ordered to pay $417 million in trial over talc cancer risks: A California jury on Monday ordered Johnson & Johnson to pay $417 million to a woman who claimed she developed ovarian cancer after using the company’s talc-based products like Johnson’s Baby Powder for feminine hygiene.<\/span><\/p>\n

The Los Angeles Superior Court jury’s verdict in favor of California resident Eva Echeverria was the largest yet in lawsuits alleging J&J failed to adequately warn consumers about the cancer risks of its talc-based products.<\/span><\/p>\n

“We are grateful for the jury’s verdict on this matter and that Eva Echeverria was able to have her day in court,” Mark Robinson, her lawyer, said in a statement.<\/span><\/p>\n

The verdict included $70 million in compensatory damages and $347 million in punitive damages. It was a major setback for J&J, which faces 4,800 similar claims nationally and has been hit with over $300 million in verdicts by juries in Missouri.<\/span><\/p>\n

“We will appeal today’s verdict because we are guided by the science, which supports the safety of Johnson’s Baby Powder,” J&J said.<\/span><\/p>\n

Echeverria’s lawsuit was the first out of hundreds of California talc cases to go to trial.<\/span><\/p>\n

The 63-year-old claimed she developed terminal ovarian cancer after decades of using J&J’s products. Her lawyers argued J&J encouraged women to use its products despite knowing of studies linking ovarian cancer to genital talc use.<\/span><\/p>\n

J&J’s lawyers countered that studies and federal agencies have not found that talc products are carcinogenic.<\/span><\/p>\n

The trial follows five prior ones in Missouri state court, where many lawsuits are pending.<\/span><\/p>\n

J&J lost four of those trials and, along with a talc supplier, has been hit with $307 million in verdicts. Before Monday, the largest verdict was for $110 million.<\/span><\/p>\n

The Missouri cases, which have largely been brought by out-of-state plaintiffs, have faced jurisdictional questions after the U.S. Supreme Court issued a ruling in June that limited where personal injury lawsuits can be filed.<\/span><\/p>\n

In a decision in a case involving Bristol-Myers Squibb Co, the Supreme Court said state courts cannot hear claims against companies that are not based in the state when the alleged injuries did not occur there.<\/span><\/p>\n

The ruling prompted a St. Louis judge, at New Jersey-based J&J’s urging, to declare a mistrial in the talc case already underway.<\/span><\/p>\n

The judge has nonetheless left the door open for the plaintiffs to argue they still have jurisdiction based on a Missouri-based bottler J&J used to package its products.<\/span><\/p>\n

The case is Echeverria et al v. Johnson & Johnson, Los Angeles Superior Court, No. BC628228.<\/span><\/p>\n

Source: https:\/\/www.reuters.com\/article\/us-johnson-johnson-cancer-lawsuit-idUSKCN1B121D<\/span><\/p>\n

\n\t\t\t
\n\t\t\t <\/div><\/div>\n\t\t